Biomedicm Virus Core (BVC) facility is a service platform that provides biosafety level II laboratory space for recombinant virus production as well as consultation, technical help and gene transfer products for University of Helsinki researchers.
AAV Gene Transfer and Cell Therapy core facility provides generation of recombinant adeno-associated viral (rAAV) preparation for academic and industrial customers in Finland as well as abroad.